Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Learn effective ways to earn more credit card rewards. Maximize your savings and enjoy additional benefits on every purchase.
27,294 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
XRP faces a volatile road ahead as escrow releases, ETF demand, and broader crypto cycles converge. Analysts weigh se...
Micron burst higher after a strong earnings report, but does micron's improved price truly reflect durable fundamenta...
As the Senate nears its August recess, crypto firms race lock on the CLARITY Act, pushing for a floor vote before law...
SpaceX captured attention with its IPO buzz, but jumping in right away can backfire. This guide explains why waiting ...
Tesla's Q2 delivery figures offer a clear window into demand trends and pricing power. This guide breaks down what to...
The heat wave turning data centers into a real-time stress test is reshaping how investors and households think about...
Anthropic faces a high-stakes regulatory battle in Washington that could redefine how AI startups grow and attract mo...
Ripple unveils a day-one Open USD partnership as XRP hovers near $1, with RLUSD clearing regulatory hurdles and insti...
SpaceX is eyed for Nasdaq-100 inclusion via a Fast Entry rule. Learn what it means for investors, how to evaluate the...
As 2026 unfolds, investors debate whether ripple worth holding through the year hinges on regulatory clarity, adoptio...
Two high-profile guests showed up in identical gowns at a celebrity wedding, highlighting how fashion choices mirror ...